PIP : Summary for PharmAthene, Inc Common Stock - Yahoo Finance

U.S. Markets open in 3 hrs 57 mins

PharmAthene, Inc. (PIP)


NYSE MKT - NYSE MKT Delayed Price. Currency in USD
Add to watchlist
3.15+0.10 (+3.28%)
At close: 4:02 PM EST
People also watch:
SIGAPLXRNNSNSSOPXA
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close3.05
Open3.10
Bid3.05 x 2000
Ask3.15 x 10000
Day's Range3.07 - 3.15
52 Week Range1.38 - 3.15
Volume1,431,029
Avg. Volume365,946
Market Cap199.63M
Beta2.40
PE Ratio (TTM)1.78
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.00 (0.00%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube17 hours ago

    ETFs with exposure to PharmAthene, Inc. : December 5, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to PharmAthene, Inc. Here are 5 ETFs with the largest exposure to PIP-US. Comparing the performance and risk of PharmAthene, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • PR Newswire19 days ago

    PharmAthene Declares $2.91 Special Cash Dividend on Common Stock

    ANNAPOLIS, Md., Nov. 17, 2016 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against anthrax, today announced that its Board of Directors has declared a special one-time cash dividend of $2.91 per share of common stock, payable on February 3, 2017 to holders of record as of January 24, 2017. The special dividend, totaling an aggregate payment of approximately $200 million, which represents approximately 98% of the after tax net cash proceeds received from SIGA, was approved by PharmAthene's Board of Directors following the Company's receipt of $83.9 million as final payment from SIGA Technologies, Inc. in satisfaction of the judgment owed by it to PharmAthene.

  • PR Newswire20 days ago

    PharmAthene Receives Final Payment from SIGA of $83.9 Million

    ANNAPOLIS, Md., Nov. 16, 2016 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against anthrax, today received a final payment from SIGA Technologies, Inc. of $83.9 million which fully satisfies the judgment owed to PharmAthene. In total, PharmAthene has received payment of approximately $217 million including interest from SIGA. Barring any unexpected material events, PharmAthene intends to distribute to its shareholders at least 90% of the after tax net cash proceeds of the $217 million in total payments it received from SIGA.